Article
18 Feb 2022
Tillis Urges FDA, USPTO To Investigate Potential False Narrative By Drug Critics
AUTHORS CONTENT
Article
25 Jan 2022
Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug
Article
29 Oct 2021
Executive Order On Promoting Competition In The American Economy: A Focus On Patent And Drug Law To Reduce Health Care Spending
Article
24 Sep 2021
Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement
Article
11 Jun 2020
FDA Launches Review Of Orange Book Patent Listing Practices
Article
08 May 2019
IPR Estoppel Applies Even After A Bench Trial On Validity
Article
07 May 2019
Communications With, And Criticism By, FDA In Analyzing Obviousness
Article
25 Apr 2019
Polymorph Patent Not Invalid As Obvious
Article
13 Nov 2018
New PTAB Pilot Program For Claim Amendments
Article
13 Aug 2018
PTAB Upholds GILENYA™ Method Of Treatment Patent, Prompting New ANDA Litigation
Article
25 Apr 2018
Prior Art Chemical Structures Must Be More Than A "Code Name"
Article
10 Jan 2018
Declarations As New Evidence To Overcome § 325(d)
Article
13 Dec 2017
Inherent Obviousness: Available IPR Rationale With A High Standard
Article
10 Oct 2017
Timely Joinder Cannot Save Untimely IPR When Nothing To Join
Article
14 Aug 2017
Genentech To Defend 3 Of 4 Herceptin® Patents Challenged By Hospira
Article
25 Jul 2017
PTAB Denies Joinder Of IPR Petitioner That Won't Take "Silent Understudy" Role
Article
09 May 2017
Product-By-Process Claims Invalid When The Process Does Not Impart Structural Or Functional Differences
Article
27 Apr 2017
Allergan Successfully Invalidates Claims Relating To Using Botox To Treat Back Pain
Article
30 Mar 2017
Unsuccessfully Using The Wayback Machine To Establish Status As A Printed Publication, PTAB Litigation Blog
Article
23 Feb 2017
Old Drug Label Still Requires Authentication of Publication Date